Evaluating the need, timing and best choice of antibiotic therapy for acute otitis media and tonsillopharyngitis infections in children

Pediatric Infectious Disease Journal

Volumn 19, Issue 12 SUPPL., 2000, Pages

  Pichichero, M E ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Acute otitis media; Cephalosporin antibiotic; Group A streptococci; Penicillin; Tonsillopharyngitis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFDINIR; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LORACARBEF; MACROLIDE; PENICILLIN DERIVATIVE; TETRACYCLINE;

ACUTE DISEASE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG PREFERENCE; HUMAN; MYRINGOTOMY; OTITIS MEDIA; PHARYNGITIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; TONSILLITIS; TREATMENT INDICATION;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; OTITIS MEDIA; PHARYNGITIS; TIME FACTORS; TONSILLITIS;

EID: 0034544703     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200012001-00001     Document Type: Article

References (97)

1. Resistant respiratory pathogens and extended-spectrum antibiotics
2. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
3. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
4. Bacteriologic response to oral cephalosporins: Are established susceptibility breakpoints appropriate in the case of acute otitis media?
5. Pharmacokinetics and pharmacodynamics of new and old antimicrobial agents for acute otitis media
6. Implications of drug-resistant Streptococcus pneumoniae for otitis media
7. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US Surveillance Study
8. Acute otitis media: Management and surveillance in an era of pneumococcal resistance: A report from the drug-resistant Streptococcus pneumoniae Therapeutic Working Group
9. Review of consensus reports on management of acute otitis media
10. Controversies in the medical management of persistent and recurrent acute otitis media
11. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis
12. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media
13. Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin
14. Interpretation of middle ear fluid concentrations of antibiotics: Comparison between ceftibuten, cefixime and azithromycin
15. Dose-dependent absorption of amoxycillin and bacampicillin
16. Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects
17. Otitis media in children
18. Otitis media
19. Otoscopy for the diagnosis of otitis media
20. Otitis media: Back to basics
21. Acute otitis media: Part I. Improving diagnostic accuracy
22. Clinical efficacy of antimicrobial drugs for acute otitis media: Metaanalysis of 5400 children from thirty-three randomized trials
23. Are antibiotics indicated as initial treatment for children with acute otitis media? A mete-analysis
24. Diagnosis antibiotic treatment of acute otitis media: Report from International Primary Care Network
25. Acute otitis media: A new treatment strategy
26. Cefdinir versus amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children
27. Five-day cefdinir course vs. ten-day cefprozil course for treatment of acute otitis media
28. Penicillin treatment of acute otitis media in children: A study of the duration inhibitor effects of amoxicillin plus clavulanate
29. Amoxicillin or myringotomy or both for acute otitis media: Results of a randomized clinical trial
30. Efficacy of amoxicillin/clavulanate for acute otitis media: Relation to Streptococcus pneumoniae susceptibility
31. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children
32. Cefprozil treatment of persistent and recurrent acute otitis media
33. Co-amoxiclav in recurrent acute otitis media: Placebo controlled study
34. Persistent acute otitis media: II. Antimicrobial treatment
35. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin
36. Acute otitis media: Part II. Treatment in an era of increasing antibiotic resistance
37. Management of acute otitis media in the 1990s: The decade of resistant pneumococcus
38. Recurrent and persistent otitis media
39. The 'in vivo sensitivity test' for acute otitis media revisited
40. Pathogens isolated during treatment failures in otitis
41. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics
42. Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate in the treatment of acute suppurative otitis media in children
43. Tympanocentesis: Why, when, how
44. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY antimicrobial surveillance program
45. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective US study
46. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study
47. Considerations in selecting an antibiotic for treatment of acute otitis media
48. Clinical implications of antibiotic resistance for management of acute otitis media
49. Strategies for dealing with amoxicillin failure in acute otitis media
50. Prevention of rheumatic fever: Treatment of the preceding streptococcic infection
51. Prophylaxis of acute rheumatic fever: By treatment of preceding pharyngitis with various amounts of depot penicillin
52. Penicillin V for group A streptococcal pharyngotonsillitis: A randomized trial of seven vs. ten days' therapy
53. Five vs. ten days of penicillin V therapy for streptococcal pharyngitis
54. Why have group A streptococci remained susceptible to penicillin? Report on a symposium
55. Treatment of streptococcal pharyngotonsillitis: Reports of penicillin's demise are premature
56. Streptococcal pharyngitis: The case for penicillin therapy
57. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: A meta-analysis supporting the concept of microbial copathogenicity
58. The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: An emerging role for the cephalosporins?
59. Recurrent group A streptococcal tonsillopharyngitis
60. Penicillin failure in streptococcal tonsillopharyngitis: Causes and remedies
61. Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis
62. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis
63. Microbial factors leading to recurrent upper respiratory tract infections
64. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children
65. Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: A placebo-controlled study
66. Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis: A randomized placebo-controlled multicentre study
67. The treatment of group A beta-hemolytic streptococcal tonsillopharyngitis and prevention of rheumatic fever
68. Comparative efficacy and safety of 5-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children
69. Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: Results of a multicenter, open comparative study
70. The role of the streptococcus in the pathogenesis of rheumatic fever
71. Adverse and beneficial effects of immediate treatment of group A betahemolytic streptococcal pharyngitis with penicillin
72. Immediate vs. delayed treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin V
73. Variables influencing penicillin treatment outcome in streptococcal tonsillopharyngitis
74. Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis
75. Managing sore throat: A literature review
76. Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy
77. Effect of treatment on streptococcal pharyngitis: Is the issue really settled?
78. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis
79. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis
80. Streptococcal pharyngitis: Placebo-controlled double-blind evaluation of clinical response to penicillin therapy
81. Effect of penicillin and aureomycin on natural course of streptococcal tonsillitis and pharyngitis
82. The effect of tonsillectomy on the incidence of streptococcal respiratory disease and its complications
83. Comparative effects of penicillin aureomycin, and terramycin on streptococcal tonsillitis and pharyngitis
84. Standardized symptomatic treatment versus penicillin as initial therapy for streptococcal pharyngitis
85. Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice
86. Open randomised trial of prescribing strategies in managing sore throat
87. Potential mechanisms for failure to eradicate group A streptococci from the pharynx
88. Streptococcal pharyngitis: Updating penicillin's role
89. The impact of dosing frequency on the efficacy of 10-day penicillin or amoxicillin therapy for streptococcal tonsillopharyngitis: A meta-analysis
90. Comparison of cefdinir and penicillin V in the treatment of pediatric tonsillopharyngitis
91. Short course antibiotic therapy for respiratory infections: A review of the evidence
92. Understanding antibiotic overuse for respiratory tract infections in children
93. Low dosage and long treatment duration of beta-lactam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae
94. Clinical importance of compliance and patient tolerance
95. Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients
96. A double-blind taste comparison of pediatric antibiotic suspensions
97. Palatability of oral antibiotics among children in an urban primary care center